Kyle R. Cowdrick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kyle R. Cowdrick has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
- Erin M. Buckley
The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, USA
8 shared publications - Seung Yup Lee
Department of Electrical and Computer Engineering, Kennesaw State University, Marietta, GA, USA
4 shared publications Eashani Sathialingam
Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA
3 shared publications- Eashani Sathialingam
Emory University, Georgia Institute of Technology, Wallace H. Coulter Department of Biomedical Engineering, Atlanta, Georgia, United States
2 shared publications Erin M. Buckley
Georgia Institute of Technology (United States)
2 shared publicationsRowan O. Brothers
Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA
2 shared publications
Latest Publications
- Open Access
- 1 April 2025
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 12 (02) , 1-22
Beneath the surface: revealing deep-tissue blood flow in human subjects with massively parallelized diffuse correlation spectroscopy
SignificanceDiffuse correlation spectroscopy (DCS) allows label-free, non-invasive investigation of microvascular dynamics deep within tissue, such as cerebral blood flow (CBF). However, the signal-to-noise ratio (SNR) in DCS limits its effective cerebral sensitivity in adults, in which the depth to the brain, through the scalp and skull, is substantially larger than in infants.AimTherefore, we aim to increase its SNR and, ultimately, its sensitivity to CBF through new DCS techniques.ApproachWe present an in vivo demonstration of parallelized DCS (PDCS) to measure cerebral and muscular blood flow in healthy adults. Our setup employs an innovative array with hundreds of thousands single photon avalanche diodes (SPAD) in a 500×500 grid to boost SNR by averaging all independent pixel measurements. We tested this device on different total pixel counts and frame rates. A secondary, smaller array was used for reference measurements from shallower tissue at lower source-detector-separation (SDS).ResultsThe new system can measure pulsatile blood flow in cerebral and muscular tissue, at up to 4 cm SDS, while maintaining a similar measurement noise as compared with a previously published 32×32 PDCS system at 1.5 cm SDS. Data from a cohort of 15 adults provide strong experimental evidence for functional CBF activity during a cognitive memory task and allowed analysis of pulse markers. Additional control experiments on muscular blood flow in the forearm with a different technical configuration provide converging evidence for the efficacy of this technique.ConclusionsOur results outline successful PDCS measurements with large SPAD arrays to enable detect CBF in human adults. The ongoing development of SPAD camera technology is expected to result in larger and faster detectors in the future. In combination with new data processing techniques, tailored for the sparse signal of binary photon detection events in SPADs, this could lead to even greater SNR increase and ultimately greater depth sensitivity of PDCS.
- 1 April 2025
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 12 (02) , 1-22
Open AccessBeneath the surface: revealing deep-tissue blood flow in human subjects with massively parallelized diffuse correlation spectroscopy
SignificanceDiffuse correlation spectroscopy (DCS) allows label-free, non-invasive investigation of microvascular dynamics deep within tissue, such as cerebral blood flow (CBF). However, the signal-to-noise ratio (SNR) in DCS limits its effective cerebral sensitivity in adults, in which the depth to the brain, through the scalp and skull, is substantially larger than in infants.AimTherefore, we aim to increase its SNR and, ultimately, its sensitivity to CBF through new DCS techniques.ApproachWe present an in vivo demonstration of parallelized DCS (PDCS) to measure cerebral and muscular blood flow in healthy adults. Our setup employs an innovative array with hundreds of thousands single photon avalanche diodes (SPAD) in a 500×500 grid to boost SNR by averaging all independent pixel measurements. We tested this device on different total pixel counts and frame rates. A secondary, smaller array was used for reference measurements from shallower tissue at lower source-detector-separation (SDS).ResultsThe new system can measure pulsatile blood flow in cerebral and muscular tissue, at up to 4 cm SDS, while maintaining a similar measurement noise as compared with a previously published 32×32 PDCS system at 1.5 cm SDS. Data from a cohort of 15 adults provide strong experimental evidence for functional CBF activity during a cognitive memory task and allowed analysis of pulse markers. Additional control experiments on muscular blood flow in the forearm with a different technical configuration provide converging evidence for the efficacy of this technique.ConclusionsOur results outline successful PDCS measurements with large SPAD arrays to enable detect CBF in human adults. The ongoing development of SPAD camera technology is expected to result in larger and faster detectors in the future. In combination with new data processing techniques, tailored for the sparse signal of binary photon detection events in SPADs, this could lead to even greater SNR increase and ultimately greater depth sensitivity of PDCS.
- 26 September 2024
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 15 (10) , 6052-6062
Stand-alone segmentation of blood flow pulsatility measured with diffuse correlation spectroscopy
We present a stand-alone blood flow index (BFI) pulse segmentation method for diffuse correlation spectroscopy that uses a wavelet-based representation of the BFI signal at the cardiac frequency in place of an exogenous physiological reference. We use this wavelet-based segmentation method to quantify BFI waveform morphology in a cohort of 30 healthy adults. We demonstrate that the waveform morphology features obtained with the wavelet approach strongly agree with those obtained using an exogenous blood pressure reference signal. These results suggest the promise of stand-alone wavelet-based BFI segmentation for quantifying BFI waveform morphological features.
- 26 September 2024
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 15 (10) , 6052-6062
Stand-alone segmentation of blood flow pulsatility measured with diffuse correlation spectroscopy
We present a stand-alone blood flow index (BFI) pulse segmentation method for diffuse correlation spectroscopy that uses a wavelet-based representation of the BFI signal at the cardiac frequency in place of an exogenous physiological reference. We use this wavelet-based segmentation method to quantify BFI waveform morphology in a cohort of 30 healthy adults. We demonstrate that the waveform morphology features obtained with the wavelet approach strongly agree with those obtained using an exogenous blood pressure reference signal. These results suggest the promise of stand-alone wavelet-based BFI segmentation for quantifying BFI waveform morphological features.
- 20 June 2024
- Published by SPIE-Intl Soc Optical Eng
- Vol. PC13007, PC1300708
Towards Surface-Correction of Deep-Tissue Blood Flow Dynamics with Massively Parallelized Diffuse Correlation Spectroscopy
Diffuse Correlation Spectroscopy (DCS) allows the optical and label-free investigation of microvascular dynamics. Commonly, DCS is implemented with highly sensitive and ultra fast single-photon avalanche diodes (SPAD) for blood flow measurements from around 1-1.5cm deep inside tissue (source detector separation of 2.5-3 cm). In parallelized DCS (pDCS), we use arrays of multiple SPADs to boost the signal-to-noise ratio by averaging many independent DCS measurements. In this study, we explored the capabilities of an innovative, massively parallelized SPAD array with 500x500 single pixels for DCS for up to 250,000 parallel DCS measurements. We can show that this massively parallelized array enables viable blood flow measurements at 2cm depth (4cm source detector separation) in human subjects. Furthermore, we applied a dual detection strategy, where a secondary SPAD array probes the superficial blood flow simultaneously as a build-in reference measurement. In addition to our main results, we test and discuss methods to correct the deep flow measurement, by including simultaneously measured flow dynamics deep and superficial tissue layers via our novel dual-SPAD array measurement setup.
- 20 June 2024
- Published by SPIE-Intl Soc Optical Eng
- Vol. PC13007, PC1300708
Towards Surface-Correction of Deep-Tissue Blood Flow Dynamics with Massively Parallelized Diffuse Correlation Spectroscopy
Diffuse Correlation Spectroscopy (DCS) allows the optical and label-free investigation of microvascular dynamics. Commonly, DCS is implemented with highly sensitive and ultra fast single-photon avalanche diodes (SPAD) for blood flow measurements from around 1-1.5cm deep inside tissue (source detector separation of 2.5-3 cm). In parallelized DCS (pDCS), we use arrays of multiple SPADs to boost the signal-to-noise ratio by averaging many independent DCS measurements. In this study, we explored the capabilities of an innovative, massively parallelized SPAD array with 500x500 single pixels for DCS for up to 250,000 parallel DCS measurements. We can show that this massively parallelized array enables viable blood flow measurements at 2cm depth (4cm source detector separation) in human subjects. Furthermore, we applied a dual detection strategy, where a secondary SPAD array probes the superficial blood flow simultaneously as a build-in reference measurement. In addition to our main results, we test and discuss methods to correct the deep flow measurement, by including simultaneously measured flow dynamics deep and superficial tissue layers via our novel dual-SPAD array measurement setup.
- Open Access
- 1 December 2023
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 28 (12) , 126005-13
Comparison of diffuse correlation spectroscopy analytical models for measuring cerebral blood flow in adults
Diffuse correlation spectroscopy (DCS) is a low-cost, non-invasive optical technology for measuring blood flow. DCS measures the temporal intensity autocorrelation () of multiply scattered light that has traveled from the source to the tissue surface. The decay rate of this curve is related to the motion of red blood cells in the underlying tissue.1,2 Correlation diffusion theory is used to estimate an index of blood flow () from . When DCS is applied in the brain, detected photons that carry information about cerebral hemodynamics have also interacted with extracerebral layers (i.e., skull, scalp, and cerebral spinal fluid) by the nature of the non-invasive measurement. Thus, signal contamination from extracerebral layers is a challenge with DCS.3,4- 1 December 2023
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 28 (12) , 126005-13
Open AccessComparison of diffuse correlation spectroscopy analytical models for measuring cerebral blood flow in adults
Diffuse correlation spectroscopy (DCS) is a low-cost, non-invasive optical technology for measuring blood flow. DCS measures the temporal intensity autocorrelation () of multiply scattered light that has traveled from the source to the tissue surface. The decay rate of this curve is related to the motion of red blood cells in the underlying tissue.1,2 Correlation diffusion theory is used to estimate an index of blood flow () from . When DCS is applied in the brain, detected photons that carry information about cerebral hemodynamics have also interacted with extracerebral layers (i.e., skull, scalp, and cerebral spinal fluid) by the nature of the non-invasive measurement. Thus, signal contamination from extracerebral layers is a challenge with DCS.3,4 - 10 October 2023
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 14 (11) , 5696-5708
Impaired cerebrovascular reactivity in pediatric sickle cell disease using diffuse correlation spectroscopy
Cerebrovascular reactivity (CVR), defined as the ability of cerebral vasculature to dilate in response to a vasodilatory stimulus, is an integral mechanism in brain homeostasis that is thought to be impaired in sickle cell disease (SCD). This study used diffuse correlation spectroscopy and a simple breath-hold stimulus to quantify CVR non-invasively in a cohort of 12 children with SCD and 14 controls. Median [interquartile range] CVR was significantly decreased in SCD compared to controls (2.03 [1.31, 2.44] versus 3.49 [3.00, 4.11] %/mmHg, p = 0.028). These results suggest DCS may provide a feasible means to routinely monitor CVR impairments in pediatric SCD.
- 10 October 2023
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 14 (11) , 5696-5708
Impaired cerebrovascular reactivity in pediatric sickle cell disease using diffuse correlation spectroscopy
Cerebrovascular reactivity (CVR), defined as the ability of cerebral vasculature to dilate in response to a vasodilatory stimulus, is an integral mechanism in brain homeostasis that is thought to be impaired in sickle cell disease (SCD). This study used diffuse correlation spectroscopy and a simple breath-hold stimulus to quantify CVR non-invasively in a cohort of 12 children with SCD and 14 controls. Median [interquartile range] CVR was significantly decreased in SCD compared to controls (2.03 [1.31, 2.44] versus 3.49 [3.00, 4.11] %/mmHg, p = 0.028). These results suggest DCS may provide a feasible means to routinely monitor CVR impairments in pediatric SCD.
- Open Access
- 1 April 2023
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 10 (02) , 025002-17
Agreement in cerebrovascular reactivity assessed with diffuse correlation spectroscopy across experimental paradigms improves with short separation regression
SignificanceCerebrovascular reactivity (CVR), i.e., the ability of cerebral vasculature to dilate or constrict in response to vasoactive stimuli, is a biomarker of vascular health. Exogenous administration of inhaled carbon dioxide, i.e., hypercapnia (HC), remains the “gold-standard” intervention to assess CVR. More tolerable paradigms that enable CVR quantification when HC is difficult/contraindicated have been proposed. However, because these paradigms feature mechanistic differences in action, an assessment of agreement of these more tolerable paradigms to HC is needed.AimWe aim to determine the agreement of CVR assessed during HC, breath-hold (BH), and resting state (RS) paradigms.ApproachHealthy adults were subject to HC, BH, and RS paradigms. End tidal carbon dioxide (EtCO2) and cerebral blood flow (CBF, assessed with diffuse correlation spectroscopy) were monitored continuously. CVR (%/mmHg) was quantified via linear regression of CBF versus EtCO2 or via a general linear model (GLM) that was used to minimize the influence of systemic and extracerebral signal contributions.ResultsStrong agreement (CCC ≥ 0.69; R ≥ 0.76) among CVR paradigms was demonstrated when utilizing a GLM to regress out systemic/extracerebral signal contributions. Linear regression alone showed poor agreement across paradigms (CCC ≤ 0.35; R ≤ 0.45).ConclusionsMore tolerable experimental paradigms coupled with regression of systemic/extracerebral signal contributions may offer a viable alternative to HC for assessing CVR.
- 1 April 2023
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 10 (02) , 025002-17
Open AccessAgreement in cerebrovascular reactivity assessed with diffuse correlation spectroscopy across experimental paradigms improves with short separation regression
SignificanceCerebrovascular reactivity (CVR), i.e., the ability of cerebral vasculature to dilate or constrict in response to vasoactive stimuli, is a biomarker of vascular health. Exogenous administration of inhaled carbon dioxide, i.e., hypercapnia (HC), remains the “gold-standard” intervention to assess CVR. More tolerable paradigms that enable CVR quantification when HC is difficult/contraindicated have been proposed. However, because these paradigms feature mechanistic differences in action, an assessment of agreement of these more tolerable paradigms to HC is needed.AimWe aim to determine the agreement of CVR assessed during HC, breath-hold (BH), and resting state (RS) paradigms.ApproachHealthy adults were subject to HC, BH, and RS paradigms. End tidal carbon dioxide (EtCO2) and cerebral blood flow (CBF, assessed with diffuse correlation spectroscopy) were monitored continuously. CVR (%/mmHg) was quantified via linear regression of CBF versus EtCO2 or via a general linear model (GLM) that was used to minimize the influence of systemic and extracerebral signal contributions.ResultsStrong agreement (CCC ≥ 0.69; R ≥ 0.76) among CVR paradigms was demonstrated when utilizing a GLM to regress out systemic/extracerebral signal contributions. Linear regression alone showed poor agreement across paradigms (CCC ≤ 0.35; R ≤ 0.45).ConclusionsMore tolerable experimental paradigms coupled with regression of systemic/extracerebral signal contributions may offer a viable alternative to HC for assessing CVR.
- 7 March 2023
- Published by SPIE-Intl Soc Optical Eng
- Vol. PC12376, 30
Pulsatile microvascular cerebral blood flow waveforms as a biomarker of vascular health (Conference Presentation)
Interpretation of cardiac pulsatility in cerebral blood flow measured with transcranial doppler ultrasound (TCD) plays an important role in neurocritical care. However, TCD is only sensitive to large arteries, whereas the optical technique diffuse correlation spectroscopy (DCS) can detect microvascular flow. We develop and apply analysis methods to quantify morphological features of cerebral blood flow waveforms measured with DCS. We characterize normative waveforms in healthy adults at rest and report a waveform response to an intervention known to induce vasodilation (hypercapnia). We further show changes in waveform morphology in subarachnoid hemorrhage (SAH) patients with cerebral vasospasm compared to healthy controls.
- 7 March 2023
- Published by SPIE-Intl Soc Optical Eng
- Vol. PC12376, 30
Pulsatile microvascular cerebral blood flow waveforms as a biomarker of vascular health (Conference Presentation)
Interpretation of cardiac pulsatility in cerebral blood flow measured with transcranial doppler ultrasound (TCD) plays an important role in neurocritical care. However, TCD is only sensitive to large arteries, whereas the optical technique diffuse correlation spectroscopy (DCS) can detect microvascular flow. We develop and apply analysis methods to quantify morphological features of cerebral blood flow waveforms measured with DCS. We characterize normative waveforms in healthy adults at rest and report a waveform response to an intervention known to induce vasodilation (hypercapnia). We further show changes in waveform morphology in subarachnoid hemorrhage (SAH) patients with cerebral vasospasm compared to healthy controls.
- Top Cited PapersOpen Access
- 30 August 2022
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 9 (S2) , S24001-65
Optical imaging and spectroscopy for the study of the human brain: status report
We have come a long way since Jöbsis first demonstrated that noninvasive cerebral monitoring was possible in humans within the near-infrared light window (approximately 700 to 1000 nm) in the late 1970s.1 What started as a tool to quantify blood oxygenation in the brain has exploded into a whole field of study that aims to exploit this window to reveal a battery of information related to human brain physiology, including brain metabolism, blood flow, autoregulation, perfusion pressure, water concentration, light scattering, exogenous contrast agents, and more. In this text, we use the term “diffuse optics” to broadly describe any technique that employs a near-infrared light source and a photodetector to capture multiply scattered photons in the diffusion limit (i.e., in the limit wherein the absorption coefficient, , is much less than the reduced scattering coefficient, , and the source-detector separation is much greater than the photon mean free path). The term “diffuse” has historical connotations in the field and reflects how near-infrared photons propagate through biological tissue. However, it should be noted that this term is in no way associated with how the field/community is organized or conducts its science. On the contrary, the breadth and depth of the progress made in the field over the past decade could only be accomplished by a cohesive, focused, and tight-knit community of researchers!- 30 August 2022
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 9 (S2) , S24001-65
Top Cited PapersOpen AccessOptical imaging and spectroscopy for the study of the human brain: status report
We have come a long way since Jöbsis first demonstrated that noninvasive cerebral monitoring was possible in humans within the near-infrared light window (approximately 700 to 1000 nm) in the late 1970s.1 What started as a tool to quantify blood oxygenation in the brain has exploded into a whole field of study that aims to exploit this window to reveal a battery of information related to human brain physiology, including brain metabolism, blood flow, autoregulation, perfusion pressure, water concentration, light scattering, exogenous contrast agents, and more. In this text, we use the term “diffuse optics” to broadly describe any technique that employs a near-infrared light source and a photodetector to capture multiply scattered photons in the diffusion limit (i.e., in the limit wherein the absorption coefficient, , is much less than the reduced scattering coefficient, , and the source-detector separation is much greater than the photon mean free path). The term “diffuse” has historical connotations in the field and reflects how near-infrared photons propagate through biological tissue. However, it should be noted that this term is in no way associated with how the field/community is organized or conducts its science. On the contrary, the breadth and depth of the progress made in the field over the past decade could only be accomplished by a cohesive, focused, and tight-knit community of researchers! - Open Access
- 24 September 2021
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 188 (3-4) , e771-e779
Repetitive Low-level Blast Exposure and Neurocognitive Effects in Army Ranger Mortarmen
Occupational exposure to repetitive, low-level blasts in military training and combat has been tied to subconcussive injury and poor health outcomes for service members. Most low-level blast studies to date have focused on explosive breaching and firing heavy weapon systems; however, there is limited research on the repetitive blast exposure and physiological effects that mortarmen experience when firing mortar weapon systems. Motivated by anecdotal symptoms of mortarmen, the purpose of this paper is to characterize this exposure and its resulting neurocognitive effects in order to provide preliminary findings and actionable recommendations to safeguard the health of mortarmen. In collaboration with the U.S. Army Rangers at Fort Benning, blast exposure, symptoms, and pupillary light reflex were measured during 3 days of firing 81 mm and 120 mm mortars in training. Blast exposure analysis included the examination of the blast overpressure (BOP) and cumulative exposure by mortarman position, as well as comparison to the 4 psi safety threshold. Pupillary light reflex responses were analyzed with linear mixed effects modeling. All neurocognitive results were compared between mortarmen (n = 11) and controls (n = 4) and cross-compared with blast exposure and blast history. Nearly 500 rounds were fired during the study, resulting in a high cumulative blast exposure for all mortarmen. While two mortarmen had average BOPs exceeding the 4 psi safety limit ( Fig. 2), there was a high prevalence of mTBI-like symptoms among all mortarmen, with over 70% experiencing headaches, ringing in the ears, forgetfulness/poor memory, and taking longer to think during the training week (n ≥ 8/11). Mortarmen also had smaller and slower pupillary light reflex responses relative to controls, with significantly slower dilation velocity (P < 0.05) and constriction velocity (P < 0.10). (A) Swarm scatter chart displaying all blast events for each mortarman on the 120 mm and 81 mm mortars (AG = assistant gunner, G = gunner, SL = squad leader, AB = ammunition bearer). Overlaid with box plots for each. Subjects with means significantly greater than 4 psi are indicated with ***P < 0.001. (B) Blast overpressure (BOP) exposure values for all mortarmen, including FDCs (FDC = fire direction center). Mortarmen experienced high cumulative blast exposure coinciding with altered neurocognition that is suggestive of blast-related subconcussive injury. These neurocognitive effects occurred even in mortarmen with average BOP below the 4 psi safety threshold. While this study was limited by a small sample size, its results demonstrate a concerning health risk for mortarmen that requires additional study and immediate action. Behavioral changes like ducking and standing farther from the mortar when firing can generally help reduce mortarmen BOP exposure, but we recommend the establishment of daily cumulative safety thresholds and daily firing limits in training to reduce cumulative blast exposure, and ultimately, improve mortarmen’s quality of life and longevity in service.
- 24 September 2021
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 188 (3-4) , e771-e779
Open AccessRepetitive Low-level Blast Exposure and Neurocognitive Effects in Army Ranger Mortarmen
Occupational exposure to repetitive, low-level blasts in military training and combat has been tied to subconcussive injury and poor health outcomes for service members. Most low-level blast studies to date have focused on explosive breaching and firing heavy weapon systems; however, there is limited research on the repetitive blast exposure and physiological effects that mortarmen experience when firing mortar weapon systems. Motivated by anecdotal symptoms of mortarmen, the purpose of this paper is to characterize this exposure and its resulting neurocognitive effects in order to provide preliminary findings and actionable recommendations to safeguard the health of mortarmen. In collaboration with the U.S. Army Rangers at Fort Benning, blast exposure, symptoms, and pupillary light reflex were measured during 3 days of firing 81 mm and 120 mm mortars in training. Blast exposure analysis included the examination of the blast overpressure (BOP) and cumulative exposure by mortarman position, as well as comparison to the 4 psi safety threshold. Pupillary light reflex responses were analyzed with linear mixed effects modeling. All neurocognitive results were compared between mortarmen (n = 11) and controls (n = 4) and cross-compared with blast exposure and blast history. Nearly 500 rounds were fired during the study, resulting in a high cumulative blast exposure for all mortarmen. While two mortarmen had average BOPs exceeding the 4 psi safety limit ( Fig. 2), there was a high prevalence of mTBI-like symptoms among all mortarmen, with over 70% experiencing headaches, ringing in the ears, forgetfulness/poor memory, and taking longer to think during the training week (n ≥ 8/11). Mortarmen also had smaller and slower pupillary light reflex responses relative to controls, with significantly slower dilation velocity (P < 0.05) and constriction velocity (P < 0.10). (A) Swarm scatter chart displaying all blast events for each mortarman on the 120 mm and 81 mm mortars (AG = assistant gunner, G = gunner, SL = squad leader, AB = ammunition bearer). Overlaid with box plots for each. Subjects with means significantly greater than 4 psi are indicated with ***P < 0.001. (B) Blast overpressure (BOP) exposure values for all mortarmen, including FDCs (FDC = fire direction center). Mortarmen experienced high cumulative blast exposure coinciding with altered neurocognition that is suggestive of blast-related subconcussive injury. These neurocognitive effects occurred even in mortarmen with average BOP below the 4 psi safety threshold. While this study was limited by a small sample size, its results demonstrate a concerning health risk for mortarmen that requires additional study and immediate action. Behavioral changes like ducking and standing farther from the mortar when firing can generally help reduce mortarmen BOP exposure, but we recommend the establishment of daily cumulative safety thresholds and daily firing limits in training to reduce cumulative blast exposure, and ultimately, improve mortarmen’s quality of life and longevity in service.
- Open Access
- 1 March 2021
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 8 (01) , 015007-13
Cerebrovascular reactivity measured in awake mice using diffuse correlation spectroscopy
Cerebrovascular reactivity (CVR), defined as the ability of the cerebral vasculature to dilate or constrict in response to a vasoactive stimulus, is an important indicator of the brain’s vascular health.1 Impaired CVR is present in numerous disease states, including cerebrovascular disease,2 – 8 stroke,9 – 12 cardiovascular disease,13,14 cardiac arrest,15 traumatic brain injury,16 – 19 diabetes,20 and sleep apnea.21 Moreover, several studies have suggested that impaired CVR may serve as a prognostic biomarker of functional outcome.22 – 25 Despite mounting evidence for the relevance of CVR as a potential disease biomarker, mechanisms of cerebrovascular dysregulation are poorly understood, and effective treatment strategies for impaired CVR are lacking.
- 1 March 2021
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 8 (01) , 015007-13
Open AccessCerebrovascular reactivity measured in awake mice using diffuse correlation spectroscopy
Cerebrovascular reactivity (CVR), defined as the ability of the cerebral vasculature to dilate or constrict in response to a vasoactive stimulus, is an important indicator of the brain’s vascular health.1 Impaired CVR is present in numerous disease states, including cerebrovascular disease,2 – 8 stroke,9 – 12 cardiovascular disease,13,14 cardiac arrest,15 traumatic brain injury,16 – 19 diabetes,20 and sleep apnea.21 Moreover, several studies have suggested that impaired CVR may serve as a prognostic biomarker of functional outcome.22 – 25 Despite mounting evidence for the relevance of CVR as a potential disease biomarker, mechanisms of cerebrovascular dysregulation are poorly understood, and effective treatment strategies for impaired CVR are lacking.